Kiniksa Pharmaceuticals International, plc Income Statement

Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 38.54M10.00M270.26M423.24M
Cost of Revenue 9.10M22.89M33.41M60.91M
Gross Profit 29.44M-12.89M236.85M362.33M
Operating items
Research & Development 56.36M86.60M135.00M112.04M99.30M65.49M76.10M111.62M
Selling, General & Administrative 9.04M21.56M34.96M45.32M85.95M97.95M129.43M168.01M
Other Operating Expenses 9.94M46.97M89.93M189.22M
Operating Expenses 65.40M108.16M169.96M157.36M195.18M210.41M295.45M468.86M
Operating Income -65.40M-108.16M-169.96M-157.36M-156.64M9.77M-25.20M-45.62M
EBIT -65.40M-108.16M-169.96M-157.36M-156.64M9.77M-25.20M-45.62M
Non-operating items
Interest & Investment Income 0.53M4.72M6.05M1.13M0.10M
Other Non Operating Income 1.13M0.10M1.25M8.54M9.46M
Net income details
EBT -64.87M-103.44M-168.05M-161.98M-164.28M95.09M-91.13M-36.15M
Tax Provisions 0.20M0.76M-2.05M5.15M1.39M-172.34M-30.74M7.04M
Profit After Tax -64.87M-103.23M-161.87M-161.38M-157.92M183.36M14.08M-43.19M
Income from Continuing Operations -65.07M-104.20M-166.01M-167.13M-165.67M267.43M-60.40M-43.19M
Consolidated Net Income -65.07M-104.20M-166.01M-167.13M-165.67M267.43M-60.40M-43.19M
Income towards Parent Company -65.07M-104.20M-166.01M-167.13M-165.67M267.43M-60.40M-43.19M
Net Income towards Common Stockholders -65.07M-104.20M-166.01M-167.13M-165.67M267.43M-60.40M-43.19M
Additional items
EPS (Basic) -35.85-3.49-2.99-2.61-2.302.640.20-0.60
EPS (Weighted Average and Diluted) -2.99-2.61-2.302.600.20-0.60
Shares Outstanding (Weighted Average) 49.47M55.55M68.08M68.89M69.53M70.34M72.20M
Shares Outstanding (Diluted Average) 68.58M70.42M71.92M71.42M
EBITDA -64.87M-103.23M-161.83M-161.45M-157.96M183.47M14.05M-43.36M
Tax Rate 1.22%33.73%